Skip to Search
Skip to Live Player
Skip to Content
Skip to Footer
Wellness Done Well | Lung Cancer Awareness
Home
Latest Stories
Latest Stories
Rock News
Entertainment
Man Cave
Latest Rock News
On Air
Dave & Chuck The Freak
About
Home
Dave & Chuck The Freak Podcast
Dave & Chuck The Freak’s Tasty Bits
Peep Show
D&C Store
YouTube
Shows
Dave and Chuck the Freak
Jade Springart
Meltdown
Aimee Brooks
WRIF Weekends
Motor City Riffs
Midnight Metal
RIFF2
Recently Played
The RIFF Wants Your Feedback
Listen + Watch
Listen + Watch
Dave & Chuck The Freak Podcast
Dave & Chuck The Freak’s Tasty Bits
Dave & Chuck The Freak Peep Show
Videos
Talkin’ Rock With Meltdown
Jade & Andy Podcast
Haunted Michigan with Meltdown
New Music Breakdown Poll
All Podcasts
Photos
Podcasts
RIFF TV
Photos
Latest Peep Shows
Contests
Events
Shop
WRIF Gear
Dave & Chuck The Freak Store
More
Connect
About WRIF | Contact Us
Ways To Rock With 101 WRIF
Download The Riff App
Sign Up For The WRIF Everything That Rocks Newsletter
Dave & Chuck the Freak’s “Unsolicited” Email
Beasley Best Community of Caring – Celebrating Women’s History Month
Advertise
Careers
Join The Cybercrew
Advertise With RIFF
101 WRIF Rock Hall
Search for:
DELIVERED BY NETA BROOKLINE
Wellness Done Well | Lung Cancer Awareness
Home
About
Wellness Done Well | Lung Cancer Awareness
Wellness Done Well | Lung Cancer Awareness
Home
About
Recent
October 28, 2024
Recently diagnosed with cancer: The surgery options you can choose from
International smoking abstinence study proves the best time to quit smoking is now, improves lung cancer survival outcomes
Should you consider a lung cancer screening?
KSP Celebrates Five Years of Dedicated Service to Providing Specialty Medications for Complex Diseases Throughout Michigan, Indiana and Ohio
Dr. Morhaf Al Achkar joins Team Karmanos as the associate center director for Education
Karmanos scientists discover treatment combination to avoid KRASG12C inhibitor drug resistance
If you aren’t getting routine cancer screenings, it may be time to start
The largest population-based study to date supports the survival benefits of immunotherapy for people with metastatic non-small cell lung cancer